We hypothesized that the insulin resistance that is present in critical illness would affect circulating adiponectin, RBP4, and leptin levels and that the improved insulin sensitivity that we observed in intensive insulin therapy (IIT) patients [7] would change the adipokine levels. The gene discussed is RBP4; the disease is Insulin resistance.